The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Eitemau Tebyg

• An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
  gan: Chenevix-Trench, Georgia, et al.
  Cyhoeddwyd: (2007)
• Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers
  gan: Spurdle, Amanda B., et al.
  Cyhoeddwyd: (2009)
• After BRCA1 and BRCA2—What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer
  gan: Cui, Jisheng, et al.
  Cyhoeddwyd: (2001)
• Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
  gan: Rebbeck, Timothy R., et al.
  Cyhoeddwyd: (2015)
• Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry
  gan: Kurian, Allison W., et al.
  Cyhoeddwyd: (2011)